Updated July 24, 2015 This content is archived.
For-Robin, founded by Kate Rittenhouse-Olson, PhD, professor of biotechnology, has been awarded $2 million from the National Cancer Institute to support promising research on a treatment for various types of cancers, including breast cancer.